Boston Globe reports pressure on people who take GLP-1s and those who skip them

A Boston Globe feature published Aug. 31 describes a widening bind for people whose bodies others consider too large: they report being criticized for using a GLP-1 medication and criticized just as sharply for declining one ^[1].

The piece, by columnist Beth Teitell, is built on interviews — a few Boston-area residents, a physician who runs a weight-management practice, a nutrition coach and a podcast host who studies weight discrimination. No polling or survey figures appear in it, so how common these encounters are has not been measured ^[1].

The Globe sets the scene with the speed of the drugs' cultural arrival. TikTok videos carrying the #Ozempic tag collected roughly 2 million views in 2021 and 1.2 billion in 2023, a jump the article attributes to a history compiled by the Medical University of South Carolina ^[1]. At the 2023 Academy Awards, host Jimmy Kimmel asked from the stage whether Ozempic might be right for him, and the phrase "Ozempic face" entered circulation through a cosmetic dermatologist ^[1].

Several people interviewed describe the pressure as coming from those closest to them. Ashley L., 37, a bartender and server from Malden who asked that only her last initial be printed, said she wants to shed weight without medication and is tired of co-workers pushing her. "The ladies I work with, they've all taken GLP-1s, and they're like, 'What are you waiting for — do you want to stay like that forever?'" she said ^[1].

Jun Ni, a railroad project manager from West Roxbury who calls herself "larger," said the urging has reached her exam room. She said she puts off medical appointments because she dreads her doctor's repeated suggestion that she start a GLP-1: "I've worked through shame and body-image issues, and I don't have any health issues. ... It feels predatory" ^[1].

Traci Finkel, 37, an executive assistant at Boston Children's Hospital, described lifelong scrutiny of her weight — her sister was taken bikini shopping while her own outing was to Weight Watchers — and compared the enthusiasm around the drugs to a cult. She also pointed to high costs even with insurance and to the expectation that a person stays on the medication long term ^[1].

Others describe the opposite penalty. Lauren Beckham Falcone, a WROR radio host, said she lost weight without drugs, wanted people to know it, then regained the weight. Now, she said, she feels insulted by what she assumes others are thinking: "It's the new embarrassing life status: She's not taking the shot" ^[1].

Virgie Tovar, who hosts the podcast "GLP-1 Truth Serum" and studies weight-based discrimination, argued that framing weight as a medical matter has handed relatives, friends and strangers a sense of permission to intervene. "But I don't think it's about health," she said, pointing to the fact that the criticism arrives whether or not someone is on a drug ^[1].

Meghan Garcia-Webb, a doctor who runs a weight-management practice in Newton, said patients bring her the same experiences. "You are policed if you are too thin," she said. "If you lose weight, people say inappropriate things to you. And if you accept yourself as you are, people ask why aren't you taking these meds?" ^[1]

Sarah Isenberg, a Boston health and nutrition coach, told the Globe that the field has spent years trying to strip shame out of obesity care and warned against substituting a different kind of pressure ^[1].

Why it matters for patients

The article places the friction in ordinary settings — a workplace break room, a family conversation, a primary care visit ^[1].

The clearest practical consequence described is Ni's account that pressure from her physician led her to delay medical care ^[1]. The piece does not say what care she is postponing or whether the delay has affected her health; that has not been reported ^[1].

The article also lists reasons people give for steering clear of the drugs: expense even when insured, the prospect of taking a medication indefinitely, side effects ranging from short-lived nausea to lasting eye damage, and a wish to change a relationship with food ^[1]. It notes that some patients with certain pre-existing conditions have been advised against the medications for safety reasons ^[1].

What remains unquantified is how many people encounter this dual judgment. The Globe's account rests on a handful of interviews in and around Boston, so the size of the phenomenon — and whether it differs by age, income or region — has not been established ^[1]. The article does not report a time frame for follow-up or any planned research into the question ^[1].